Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia and is ranked as the 6th leading cause of death in the US. The prevalence of AD and dementia is steadily increasing and expected cases in USA is 14.8 million by 2050. Neuroinflammation and gradual neurodegeneration occurs in Alzheimer’s di...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jianwen, Zhang, Shanjin, Wu, Lule, Kumar, Gajendra, Liao, Yuanhang, GK, Pratap, Fan, Huizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577554/
https://www.ncbi.nlm.nih.gov/pubmed/36268188
http://dx.doi.org/10.3389/fnagi.2022.1019187

Ejemplares similares

Ejemplares similares